CE for Pharmacists & Technicians - Getting Under the Skin: New Medications for Dermatologic Conditions

by Courtney Quinn PharmD, Deanna Jacobs PharmD, Joyce Hu, 2024 PharmD Candidate, Lindsey Paul, 2025 PharmD Candidate, Anthony Rende, 2026 PharmD Candidate, Drew Vander Velden PharmD, Charisse Yan, 2025 PharmD Candidate, Amanda Margolis, PharmD, MS, BCACP

Learning Objectives:

• Describe the pathophysiology and symptoms of plaque psoriasis, generalized pustular psoriasis flares, and atopic dermatitis.
• Describe the mechanism of action for newly approved dermatologic agents.
• Describe the anticipated place in therapy for newly approved dermatological agents.
• List adverse effects for newly approved dermatological agents

​Keywords: Dermatitis, Atopic, Interleukin-17, Tumor Necrosis Factor-alpha, Tapinarof, Cytokines, Biological Products, Financial Stress, Quality of Life, Drug Approval, Mental Health, Psoriasis, Immune System, Keratinocytes, Interleukin-23, Cell Proliferation, Mutation​

Download PDF

2023 November/December Table of Contents